Robin Lesley is an accomplished scientist with extensive experience in translational medicine and clinical biomarkers, currently serving as the Director and Translational Medicine Lead for Hematology at AstraZeneca since January 2021. Previous roles include Sr. Scientist and Clinical Biomarker Lead at Amgen, where responsibility encompassed developing strategies for immune-oncology programs, as well as leading clinical biomarker efforts in multiple myeloma and AML. Earlier positions included Sr. Research Associate at Genentech, where Robin managed oncology and immunology research projects, and Postdoctoral Fellow at the University of Washington, focusing on innate immunity in mycobacterial infections. Educational qualifications include a PhD in Biomedical Sciences from the University of California, San Francisco, and a BS in Biology from Stanford University. Robin also actively participates in volunteer initiatives, contributing to educational projects in the community.
This person is not in any teams
This person is not in any offices